Produkte zum Thema: JAK-Inhibitor

1-Boc-3-azetidinon

Ruxolitinib API Pulver

Oclacitinib Maleat

Abrocitinib

Baricitinib

4-Methyl-1H-Pyrrolo[2, 3-D]Pyrimidin

Oclacitinib Maleat

Upadacitinib Intermediat

Ruxolitinib

Upadacitinib Hemihydrat

7h-Pyrrolo[2, 3-D]Pyrimidin-4-Ol

Benzyl-3-methylamino-4-methyl-piperidindihydrochlorid

Oclacitinib Maleat

2,4-Dichlor-7H-Pyrrolo[2,3-d]Pyrimidin

Tofacitinib Citrat

2-(1-(Ethylsulfonyl)azetidin-3-yliden)acetonitril

3-Cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitril

Upadacitinib Hemihydrat

Oclacitinib Maleat

Baricitinib

(3R,4R)-1-Benzyl-4-Methyl-3-Methylamino-Piperidin Dihydrochlorid

Deucravacitinib

Momelotinib

Baricitinib